Invention Grant
- Patent Title: SirT inhibitors that bind to NAD
- Patent Title (中): 结合NAD的SirT抑制剂
-
Application No.: US12423751Application Date: 2009-04-14
-
Publication No.: US08486990B2Publication Date: 2013-07-16
- Inventor: Andrew Napper , Peter DiStefano , Rory A. Curtis , Jeffrey Hixon , Thomas McDonagh , L. Julie Huber , Jonathan M. Solomon , Russell J. Thomas , Jean-Francois Pons
- Applicant: Andrew Napper , Peter DiStefano , Rory A. Curtis , Jeffrey Hixon , Thomas McDonagh , L. Julie Huber , Jonathan M. Solomon , Russell J. Thomas , Jean-Francois Pons
- Applicant Address: US MA Cambridge
- Assignee: Elixir Pharmaceuticals, Inc.
- Current Assignee: Elixir Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Lando & Anastasi LLP
- Main IPC: A61K31/403
- IPC: A61K31/403 ; C07D209/56
Abstract:
Compound of formula (I) and methods of treating disorders by administering a compound of formula (I) are described herein. Examples of disorders include neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders.
Public/Granted literature
- US20090306168A1 SirT Inhibitors That Bind to NAD Public/Granted day:2009-12-10
Information query
